MichaelSethRabinMD

Oncology • Boston, MA

Hematologic Oncology, Thoracic Cancer

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Rabin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rabin's full profile

Already have an account?

Office
450 Brookline Ave. D1240
Dana Farber Cancer Institute
Boston, MA 02215
Phone+1 617-632-6049

Fax+1 617-632-5786
Is this information wrong?

Education & Training

Beth Israel Hospital1985 - 1988
NYU Grossman School of MedicineResidency, Internal Medicine, 1981 - 1984
Weill Cornell MedicineClass of 1981

Certifications & Licensure

NY State Medical License 1982 - Present
NH State Medical License 2009 - Present
MA State Medical License 1987 - 2025
CT State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

1 citations
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 inNUT Carcinoma Harboring aSplice Site Mutation.
Michael L Cheng, Yeying Huang, Nhi Luong, Jaclyn LoPiccolo, Mizuki Nishino, Lynette M Sholl, Lucian R Chirieac, Alison D Santucci, Michael S Rabin, Pasi A Jänne, Shode...> ;JCO Precision Oncology. 2023 Jun 1
1 citations
Safety of image guided research biopsies in patients with thoracic malignancies.
Steffan K Soosman, Matthew P Schenker, Emanuele Mazzola, Emma Voligny, Anna Smokovich, Camden Bay, Tom Nguyen, Kesi Michael, Pasi A Jänne, Michael Rabin, Daniel I Glaz...> ;Lung Cancer. 2022 Nov 1
7 citations
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.
Ibiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, Subba R Digumarthy, Jessica J Lin, Justin F Gainor, Michael S Rabin, Rebecca S Heist, Alona Muzikansky, Alic...> ;JCO Precision Oncology. 2022 May 1
9 citations
Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT.
Mary E Cooley, Emanuele Mazzola, Niya Xiong, Fangxin Hong, David F Lobach, Ilana M Braun, Barbara Halpenny, Michael S Rabin, Ellis Johns, Kathleen Finn, Donna Berry, R...> ;Journal of Pain and Symptom Management. 2022 Apr 1
2 citations
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content.
Catherine B. Meador, Marina S.D. Milan, Emmy Y. Hu, Mark M. Awad, Michael S. Rabin, Cloud P. Paweletz, Ryan J. Hartmaier, G. Laus, Geoffrey R. Oxnard> ;JCO Precision Oncology. 2021 Jun 1
57 citations
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.
Xinan Wang, Biagio Ricciuti, Tom C. Nguyen, Xihao Li, Michael S. Rabin, Mark M. Awad, Xihong Lin, Bruce E. Johnson, David C. Christiani> ;Cancer Research. 2021 Mar 2
12 citations
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis.
Yi Lee, Evan W Clark, Marina S.D. Milan, Christine Champagne, Kesi Michael, Mark M. Awad, David A. Barbie, Michael Cheng, Kenneth L. Kehl, J. Paul Marcoux, Michael S. ...> ;JCO Precision Oncology. 2020 Sep 21
8 citations
Identification of a RAS-activating TMEM87A-RASGRF1 fusion in an exceptional responder to sunitinib with non-small cell lung cancer
Alissa J. Cooper, Yoshihisa Kobayashi, Dewey Kim, Sarah E. Clifford, Sasha Kravets, Suzanne E. Dahlberg, Emily S. Chambers, Jiaqi Li, Deepa Rangachari, Tom C. Nguyen, ...> ;Clinical Cancer Research. 2020 Aug 1
2 citations
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome
Hye Sun Park, Suzanne E. Dahlberg, Christine A. Lydon, Tetsuro Araki, Hiroto Hatabu, Michael S. Rabin, Bruce E. Johnson, Mizuki Nishino> ;The Oncologist. 2019 Aug 1
19 citations
Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.
Tetsuro Araki, Suzanne E. Dahlberg, Tomoyuki Hida, Christine A. Lydon, Michael S. Rabin, Hiroto Hatabu, Bruce E. Johnson, Mizuki Nishino> ;European Journal of Radiology Open. 2019 Jan 1
466 citations
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
Geoffrey R. Oxnard, Yuebi Hu, Kathryn Finch Mileham, Hatim Husain, Daniel B. Costa, Philip Tracy, Nora Feeney, Lynette M. Sholl, Suzanne E. Dahlberg, Amanda J. Redig, ...> ;JAMA Oncology. 2018 Nov 1
14 citations
Algorithm-based decision support for symptom self-management among adults with Cancer: results of usability testing
Mary E. Cooley, Janet L. Abrahm, Donna L. Berry, Michael S. Rabin, Ilana M. Braun, Joanna Paladino, Manan M. Nayak, David F. Lobach> ;BMC Medical Informatics and Decision Making. 2018 May 29
5 citations
Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non–Small-Cell Lung Cancer
Raymond H. Mak, Gretchen Hermann, Hugo J.W.L. Aerts, Elizabeth H. Baldini, Aileen B. Chen, David Kozono, Michael S. Rabin, Scott J. Swanson, Yu-Hui Chen, Paul J. Catal...> ;JCO Precision Oncology. 2018 May 14
4 citations
Clinician perspectives on symptom and quality of life experiences of patients during cancer therapies: Implications for eHealth
Donna L. Berry, Manan M. Nayak, Janet L. Abrahm, Ilana M. Braun, Michael S. Rabin, Mary E. Cooley> ;Psycho-Oncology. 2017 Jul 3
19 citations
Patient and caregiver perspectives on decision support for symptom and quality of life management during cancer treatment: Implications for eHealth
Mary E. Cooley, Manan M. Nayak, Janet L. Abrahm, Ilana M. Braun, Michael S. Rabin, Jane Brzozowski, Christopher S. Lathan, Donna L. Berry> ;Psycho-Oncology. 2017 Aug 1
37 citations
Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non-Small-Cell Lung Cancer.
David M. Jackman, Yichen Zhang, Carole Kathleen Dalby, Tom C. Nguyen, Julia M. Nagle, Christine A. Lydon, Michael S. Rabin, Kristen K. McNiff, Belen Fraile, Joseph O. ...> ;Journal of Oncology Practice. 2017 Mar 4
1 citations
Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy
Vishesh Agrawal, J. Paul Marcoux, Michael S. Rabin, Inna Vernovsky, Jon O. Wee, Raymond H. Mak> ;Advances in Radiation Oncology. 2016 Apr 1
666 citations
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Daniel P. Cahill, Amaro Taylor-Weiner, Robert T. Jones, Eliezer M. Van Allen, Michael S. Lawrence, Peleg M....> ;Cancer Discovery. 2015 Nov 1
4 citations
Recurrent radiation necrosis in the brain following stereotactic radiosurgery
Gregory M. Parker, Ian F. Dunn, Shakti Ramkissoon, Jonathan D. Eneman, Michael S. Rabin, Nils D. Arvold> ;Practical Radiation Oncology. 2015 May 1
51 citations
Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, Tetsuro Araki, Christine A. Lydon, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Bruce E. Johnson> ;European Journal of Radiology. 2015 May 1
74 citations
A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
David M. Jackman, Leigh Anne Cioffredi, Lorraine Jacobs, Farhana Sharmeen, Linda K. Morse, Joan Lucca, Scott R. Plotkin, Paul Marcoux, Michael S. Rabin, Thomas J. Lync...> ;Oncotarget. 2015 Mar 2
30 citations
Feasibility of using algorithm-based clinical decision support for symptom assessment and management in lung cancer.
Mary E. Cooley, Traci M. Blonquist, Paul J. Catalano, David F. Lobach, Barbara Halpenny, Ruth McCorkle, Ellis Johns, Ilana M. Braun, Michael S. Rabin, Fatma Zohra Mata...> ;Journal of Pain and Symptom Management. 2015 Jan 1
16 citations
Creating Computable Algorithms for Symptom Management in an Outpatient Thoracic Oncology Setting
Mary E. Cooley, David F. Lobach, Ellis Johns, Barbara Halpenny, Toni Ann Saunders, Guilherme Del Fiol, Michael S. Rabin, Pamela Calarese, Isidore Berenbaum, K S Zaner,...> ;Journal of Pain and Symptom Management. 2013 Dec 1
43 citations
Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.
Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson> ;Journal of Thoracic Oncology. 2013 Aug 1
33 citations
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy
Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Nikhil H. Ramaiya, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson> ;Cancer. 2013 Nov 1
Join now to see all

Press Mentions

Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019